US44916K1060
© BusinessWire
27.01.2026
HYPR
LISTED
NASDAQ
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced results from the largest data set to date evaluating stroke detection with the Swoop® system. This data provides strong evidence supp...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
HYPR
LISTED
NASDAQ
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the American Society of Neuroimaging (ASN) Annual Meeting in Sa...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2026
HYPR
LISTED
NASDAQ
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the enrollment of the first patient in the Contrast PMR study, a prospective, multi-center clinical study designed to evaluate the fe...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
12.01.2026
HYPR
LISTED
NASDAQ
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31,...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
06.01.2026
HYPR
LISTED
NASDAQ
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the first peer-reviewed publication in Clinical Neuroimaging, demonstrating the positive economic impact of implementing the portable...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces Regulatory Approval of the Swoop® System in India
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the Swoop® system has received regulatory approval in India from the Central Drugs Standard Control Organization (CDSCO), opening acc...
Themefolio
Profiler
Peergroup
© BusinessWire
15.12.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it has received FDA clearance for a new multi-direction diffusion-weighted imaging (DWI) software sequence. This advancement del...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (E...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2025
HYPR
LISTED
NASDAQ
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the strengthening of the company’s initiatives to improve global brain health in underserved settings through a Gates Foundation gran...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2025 financial results and provided a business update.
“In the third quarter, we began to reap th...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report full financial results for the third quarter 2025 on Thursday, November 13, 2025. Management will host a correspo...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces Pricing of $17.5 Million Public Offering
News Preview
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has priced its previously announced underwritten public offering of 14,000,000 shares of the Company’s Class A common stock at a public offering price of $1.25 per share. All of the shares in the offering are being sold by Hyperfine. In addition, Hyperfine has granted...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
15.10.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces Proposed Public Offering
News Preview
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase Class A common stock. All securities to be sold in the offering will be sold by Hyperfine. In addit...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
HYPR
LISTED
NASDAQ
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited financial results for the third quarter ended September 30, 2025.
“In the third quarter, we saw strong marke...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
HYPR
LISTED
NASDAQ
Hyperfine Swoop® System Referenced in France’s Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that its distribution partner, UpCare Europe SAS (UpCare), has been awarded a national referencing for the Swoop® system by UniHA (Un...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
HYPR
LISTED
NASDAQ
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the launch of the Portable Ultra-Low-Field Scientific Exchange (PULSE), a subscription-based platform designed to empower a global co...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
HYPR
LISTED
NASDAQ
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software. These approvals, which closely f...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced their schedule for upcoming investor conferences.
Hyperfine will discuss with investors recently announced mile...
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance imaging (MRI) system for the brain—the Swoop® system—today announced the enrollment of the first patients in the PRIME (Portable Rapid Imaging for Medical Emergencies) study...
Themefolio
Profiler
Peergroup
© BusinessWire
30.07.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the second quarter 2025 on Wednesday, August 13, 2025. Management will host a corresponding...
Themefolio
Profiler
Peergroup
© BusinessWire
28.07.2025
HYPR
LISTED
NASDAQ
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer’s Association International Conference
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced promising early results from the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) study presented at the 2025 Alzheimer’s Associat...
Themefolio
Profiler
Peergroup
© BusinessWire
24.07.2025
HYPR
LISTED
NASDAQ
Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced two significant advancements highlighting the potential of its innovative MRI technology to expand dementia screening, enhance monito...
Themefolio
Profiler
Peergroup
© BusinessWire
23.07.2025
HYPR
LISTED
NASDAQ
Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced the commercial launch of the Optive AI™ software for existing Swoop® system customers. Optive AI™ software, which also powers the tra...
Themefolio
Profiler
Peergroup
© BusinessWire
17.07.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced today the first commercial sales of the next-generation Swoop® system powered by proprietary Optive AI™ software. Both of these pioneering...
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced the appointments of Rob Fasciano, PhD, as Chief Regulatory and Quality Officer, and Rafael O’Halloran, PhD, as Vice President of Technology...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced today FDA clearance of its most significant technological advancement to date. The clearance includes an entirely new portable MRI scanner...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced FDA clearance of its next-generation software. This tenth-generation release delivers a substantial leap in image quality for...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference on Thursday, June 5th at 4:20pm Eastern T...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025. Management will host a correspond...
Themefolio
Profiler
Peergroup
© BusinessWire
15.04.2025
HYPR
LISTED
NASDAQ
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system, first approved in 2021—today announced the enrollment of initial patients in the NEURO PMR (Neurological Evaluation in the Offic...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.03.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and prov...
Themefolio
Profiler
Peergroup
© BusinessWire
17.03.2025
HYPR
LISTED
NASDAQ
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a strategic collaboration with NVIDIA. This collaboration leverages NVIDIA AI expertise and accelerated computing...
Themefolio
Profiler
Peergroup
© BusinessWire
04.03.2025
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025. Management will h...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
HYPR
LISTED
NASDAQ
Hyperfine Announces $6.0 Million Registered Direct Offering
News Preview
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company’s Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warr...
Themefolio
Profiler
Peergroup
© BusinessWire
06.02.2025
HYPR
LISTED
NASDAQ
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of two studies at the 2025 International Stroke Conference (ISC), which provide evidence...
Themefolio
Profiler
Peergroup
© BusinessWire
17.12.2024
HYPR
LISTED
NASDAQ
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced further global expansion of its commercial operations through agreements with experienced distributors to support...
Themefolio
Profiler
Peergroup
© BusinessWire
05.12.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today highlighted data and conclusions presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chica...
Themefolio
Profiler
Peergroup
© BusinessWire
03.12.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the appointment of Chi Nguyen as Vice President of Office Strategy and Partnerships and Rafael Donnay as Vice Pre...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
HYPR
LISTED
NASDAQ
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the issuance of new MRI standards by the Intersocietal Accreditation Commission (IAC), a leading CMS-approved accrediting bo...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that ten scientific abstracts highlighting ultra-low-field imaging will be presented at the Radiological Society of North Am...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming BTIG Digital Health Forum on Monday, November 25, 2024. Management will also participate in...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces European Launch with CE Approval
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation (MDR,...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer’s disease w...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the third quarter 2024 on Tuesday, November 12, 2024. Management will host a corre...
Themefolio
Profiler
Peergroup
© BusinessWire
01.10.2024
HYPR
LISTED
NASDAQ
Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today congratulates investigators at Johns Hopkins Hospital and the University of Texas-Houston on the publication of an exciting study usin...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2024
HYPR
LISTED
NASDAQ
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of interim data supporting the role portable ultra-low-field MRI can play in acute stroke workup in a hospi...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2024
HYPR
LISTED
NASDAQ
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2024
HYPR
LISTED
NASDAQ
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
News Preview
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming H.C. Wainwright 26th Annual Global Investment Conference. Members of management are schedul...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.05.2024
HYPR
LISTED
NASDAQ
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
News Preview
GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update....
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2024
HYPR
LISTED
NASDAQ
Thinking about buying stock in Applied UV, Tilray Brands, Hyperfine, Smart Sand, or Nordic American Tankers?
News Preview
NEW YORK , Jan. 12, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AUVI, TLRY, HYPR, SND, and NAT.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserv...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
